6 / 1

600%

1.What is your current role?

CNS

Resident doctor (Junior/SHO)

ST3-5 (or equivalent)

ST5+ (or equivalent)

Consultant (or equivalent)

2.What is your region?

London

East Midlands

West Midlands

East of England

Kent, Surrey & Sussex

North West

North East

South Central

South West

Yorkshire and Humber

Northern Ireland

Scotland

Wales

Not working in UK

3.Do you have agreed guidance for NMIBC within your department?

NICE guidelines

EAU guidelines

Local protocol

Not aware of agreed protocol within team

4.Which guidance do you personally use for NMIBC surveillance?

NICE

EAU

Local protocol

I personalise surveillance for each patient

5.How long do you follow low-risk NMIBC for?

1 year

2 years

3 years

4 years

5 years

more

6.How long do you follow Intermediate-risk NMIBC for?

1 year

2 years

3 years

4 years

5 years

more

7.On the spot, what do you think is the risk category for:
a 62-year-old patient with
A single low-grade (G1) pTa lesion measuring 1 cm,
who has a history of a similar lesion resected 7 years ago?

Low Risk

Intermediate risk

High risk

8.On the spot, what do you think is the risk category for:
a 68-year-old patient with
Multiple low-grade (G1) pTa lesions, each smaller than <1 cm, and
No previous history of bladder cancer?

Low Risk

Intermediate Risk

High Risk

9.On the spot, what do you think is the risk category for:
an 81-year-old patient with
a single low-grade (G2) pTa lesion measuring 1 cm,
NO previous history of bladder cancer?

Low Risk

Intermediate Risk

High Risk

10.What is the risk of recurrence that you would find acceptable on discharging the patient?

<30%

<20%

<10%

<5%

0%

11.Can you provide us with your work email address?